Market capitalization | $230.25m |
Enterprise Value | $141.31m |
P/E (TTM) P/E ratio | 15.28 |
EV/FCF (TTM) EV/FCF | 7.82 |
EV/Sales (TTM) EV/Sales | 3.03 |
P/S ratio (TTM) P/S ratio | 4.94 |
P/B ratio (TTM) P/B ratio | 1.87 |
Dividend yield | 1.79% |
Last dividend (FY23) | $1.19 |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
1 Analyst has issued a forecast Utah Medical Products, Inc.:
1 Analyst has issued a forecast Utah Medical Products, Inc.:
Jun '24 |
+/-
%
|
||
Revenue | 47 47 |
10%
10%
|
|
Gross Profit | 24 24 |
7%
7%
|
|
EBITDA | 19 19 |
26%
26%
|
EBIT (Operating Income) EBIT | 15 15 |
20%
20%
|
Net Profit | 16 16 |
9%
9%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology. The company was founded on April 21, 1978 and is headquartered in Midvale, UT.
Head office | United States |
CEO | Kevin Cornwell |
Employees | 197 |
Founded | 1978 |
Website | www.utahmed.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.